Need a specific person's email?
Browse Ikena Oncology (Merged with ImageneBio)'s employee directory (about 12 employees) and reveal verified emails free.
Ikena Oncology (Merged with ImageneBio) Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Based in Boston, Massachusetts, Ikena Oncology is a biotechnology research company focused on designing and developing small-molecule therapies for solid tumors. The organization collaborates with partners to advance oncology programs and has expanded its capabilities through strategic corporate moves, including the 2023 acquisition of Pionyr Immunotherapeutics. In 2025, the company merged with ImageneBio, forming a combined entity that operates under the ImageneBio name. Its customers are typically other biopharmaceutical and biotechnology groups seeking collaboration in cancer drug development. Positioned in the biotechnology research sector, the firm concentrates on targeted approaches to oncology. The business operates with a relatively small team based in Boston, reflecting a focused research footprint.
1-888-653-2347 
support@leadiq.com 
